Monday, November 3, 2025
25.6 C
Lagos

CBN: ‘BVN Issued in Nigeria Has No Expiry Date’

The attention of the Central Bank of Nigeria (CBN) has been drawn to reports suggesting that the Bank Verification Number (BVN) issued by the Bank in collaboration with the Nigeria Inter-Bank Settlement System (NIBSS) expires after a ten-year period.

Contrary to these claims, we wish to clarify that the BVN issued in Nigeria has no expiry date. Once a customer’s biometrics have been captured and enrolled in the database of NIBSS, the BVN remains for life.

However, the Regulatory Framework for BVN issued by the CBN in 2021 stipulates that customers can only change their records due to certain conditions spelt out in the document and after being cleared by relevant authorities.

Therefore, we urge bank customers in the country, especially those whose biometrics have been captured by the system, to continue using their unique identifiers as they last their entire lifetime. Be guided accordingly.  

Isa AbdulMumin PhD

Ag. Director, Corporate Communications

Central Bank of Nigeria

spot_img
spot_img
spot_img

Hot this week

2025 Almond Insurance Industry Awards Holds Friday, Nov 7 in Lagos

All is now set for the 2025 Almond Insurance...

Stanbic IBTC Bank Nigeria PMI: Output Growth Hits 6-Month High in October

October data pointed to improved growth momentum in the...

Emirates Rolls out 700 Exclusive Winter Deals with My Emirates Pass

Emirates Airlines has announced exclusive winter offers with My...

Sterling HoldCo Builds on Upward Earnings Trajectory with 127% Profit Growth

Sterling Financial Holdings Company Plc has announced its unaudited...

Topics

Fela’s Afrobeat Rebellion Aligns with Ecobank’s Commitment to Promoting African Heritage

Ecobank Nigeria says the ongoing “Fela Kuti: Afrobeat Rebellion”...

Taxation of Housing in Africa

The Centre for Affordable Housing Finance (AUHF) in Africa...

Kenya, 1st Country to Launch ‘Novartis Access’ for Affordable Health

Novartis has announced the launch of Novartis Access in Kenya, the first country to benefit from a portfolio of 15 affordable medicines to treat cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The Novartis portfolio is being offered to the Kenyan government, non-governmental organisations and other public-sector healthcare providers for USD 1 per treatment, per month.

World Pension Summit Innovation Award 2016

The World Pension Summit and Pensions & Investments are...

Jumia Partners FG to Accelerate Nigeria’s E-Commerce Growth, Digital Inclusion

In a decisive move to advance Nigeria’s e-commerce sector...

CEOs Seek Repeal of Governance Code

Two chief executive officers have strongly canvassed immediate repeal...
spot_img

Related Articles

Popular Categories

spot_imgspot_img